GENTA INCORPORATED /DE/
4, 2000-04-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: UNIFY CORP, SC 13G/A, 2000-04-11
Next: MERRILL LYNCH LIFE VARIABLE ANNUITY SEPARATE ACCOUNT A, 497, 2000-04-11




                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                     FORM 4

                  STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

|_|   Check this box if no longer subject to Section 16. Form 4 or Form 5
      obligations may continue. See Instruction 1(b).

================================================================================
1. Name and Address of Reporting Person*

   Rosenwald, M.D. Lindsay A.
- --------------------------------------------------------------------------------
   (Last)               (First)                 (Middle)


   787 Seventh Avenue, 48th Floor
- --------------------------------------------------------------------------------
                                    (Street)


   New York                NY                  10019
- --------------------------------------------------------------------------------
   (City)               (State)                 (Zip)


================================================================================
2. Issuer Name and Ticker or Trading Symbol

   Genta, Inc.  (GNTA)
================================================================================
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)


================================================================================
4. Statement for Month/Year

   March 2000
================================================================================
5. If Amendment, Date of Original (Month/Year)


================================================================================
6. Relationship of Reporting Person to Issuer
   (Check all applicable)

   |_|   Director                             |X|   10% Owner
   |_|   Officer (give title below)           |_|   Other (specify below)


================================================================================
7. Individual or Joint/Group Filing (Check Applicable Line)

   |_|  Form filed by one Reporting Person
   |X|  Form filed by more than one Reporting Person

================================================================================

* If the Form is filed by more than one Reporting Person, see Instruction
  4(b)(v).

================================================================================
           Table I -- Non-Derivative Securities Acquired, Disposed of,
                             or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
                                                                                                     6.
                                                      4.                              5.             Owner-
                                                      Securities Acquired (A) or      Amount of      ship
                                         3.           Disposed of (D)                 Securities     Form:     7.
                                         Transaction  (Instr. 3, 4 and 5)             Beneficially   Direct    Nature of
                           2.            Code         ----------------------------    Owned at End   (D) or    Indirect
1.                         Transaction   (Instr. 8)                   (A)             of Month       Indirect  Beneficial
Title of Security          Date          ------------     Amount      or     Price    (Instr. 3      (I)       Ownership
(Instr. 3)                 (mm/dd/yy)     Code     V                  (D)             and 4)         (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                        <C>            <C>      <C>    <C>         <C>    <C>       <C>           <C>       <C>

- ------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                By Aries
                                                                                                                Domestic Fund,
Common Stock               03/31/00       P               24,619       A      $8.998   29,620,438     I         L.P. (1)
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                By Aries
                                                                                                                Domestic Fund
Common Stock               03/31/00       P                3,722       A      $8.998   29,620,438     I         II, L.P. (1)
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                By The Aries
Common Stock               03/31/00       P               51,659       A      $8.998   29,620,438     I         Master Fund II (1)
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.


                                   Page 1 of 3
<PAGE>

FORM 4 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
            (e.g., puts, calls, warrants, options, convertible securities)

================================================================================
<TABLE>
<CAPTION>
                                                                                                          9.        10.
                                                                                                          Number    Owner-
                                                                                                          of        ship
                    2.                                                                                    Deriv-    Form of
                    Conver-                    5.                              7.                         ative     Deriv-   11.
                    sion                       Number of                       Title and Amount           Secur-    ative    Nature
                    of                         Derivative    6.                of Underlying     8.       ities     Secur-   of
                    Exer-             4.       Securities    Date              Securities        Price    Bene-     ity:     In-
                    cise     3.       Trans-   Acquired (A)  Exercisable and   (Instr. 3 and 4)  of       ficially  Direct   direct
                    Price    Trans-   action   or Disposed   Expiration Date   ----------------  Deriv-   Owned     (D) or   Bene-
1.                  of       action   Code     of(D)         (Month/Day/Year)            Amount  ative    at End    In-      ficial
Title of            Deriv-   Date     (Instr.  (Instr. 3,    ----------------            or      Secur-   of        direct   Owner-
Derivative          ative    (Month/  8)       4 and 5)      Date     Expira-            Number  ity      Month     (I)      ship
Security            Secur-   Day/     ------   ------------  Exer-    tion               of      (Instr.  (Instr.   (Instr.  (Instr.
(Instr. 3)          ity      Year)    Code V    (A)   (D)    cisable  Date     Title     Shares  5)       4)        4)       4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                 <C>      <C>      <C>  <C>  <C>   <C>    <C>      <C>      <C>       <C>     <C>      <C>       <C>      <C>

- ------------------------------------------------------------------------------------------------------------------------------------
N/A
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
Explanation of Responses:

(1)   See Attachment A

*     Paramount Capital Asset Management, Inc. ("PCAM") is the general partner
      of each of the Aries Domestic Fund, L.P. ("Aries I") and Aries Domestic
      Fund II, L.P. ("Aries II"), each a Delaware limited partnership, and also
      serves as the investment manager of the Aries Master Fund II, a Cayman
      Island exempted company (the "Master Fund"), which also owns securities of
      the Issuer. Dr. Rosenwald is the chairman and sole stockholder of PCAM. As
      a result, Dr. Rosenwald and PCAM may be deemed to have voting and
      investment control over the securities of the issuer owned by the Aries
      Funds under Rule 16a-(a)(1) of the Securities Exchange Act of 1934. Dr.
      Rosenwald and PCAM disclaim beneficial ownership of the securities held by
      the Aries Funds, except to the extent of its pecuniary interest therein,
      if any.


**  Intentional misstatements or omissions of facts constitute Federal Criminal
    Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).


/s/ Lindsay A. Rosenwald, M.D.                                April 7, 2000
- ---------------------------------------------            -----------------------
** Signature of Reporting Person                                  Date

Note: File three copies of this Form, one of which must be manually signed. If
      space provided is insufficient, see Instruction 6 for procedure.


                                   Page 2 of 3


<PAGE>

                                  Attachment A

Securities beneficially owned by Dr. Rosenwald are presented on an as-converted
basis and consist of the following:

1.    Warrants to purchase 25,833 shares of Series D Preferred Stock, which
      convert into 2,919,602 shares of Common Stock owned directly by Dr.
      Rosenwald and Class D Warrants to purchase 129,163 shares of Common Stock
      owned directly by Dr. Rosenwald.

2.    12,129,036 shares of common stock of the Issuer, par value $0.01 per share
      (the "Common Stock") and warrants to purchase 5,206,471 shares of Common
      Stock owned by The Aries Master Fund II, a Cayman Island Exempted Company
      (the "Master Fund"). Includes 5,267,232 shares of Common Stock owned
      directly by the Master Fund and 1,334,018 shares of Common Stock issuable
      upon conversion of 180,700 shares of Series A Convertible Preferred Stock
      owned by the Master Fund and 5,540,240 shares of Common Stock issuable
      upon conversion of 49,020 shares of Series D Convertible Preferred Stock.
      Also includes 73,463 shares of Common Stock issuable upon conversion of
      650 shares of Series D Convertible Preferred Stock underlying warrants to
      purchase such shares owned by the Master Fund; Bridge Loan and Line of
      Credit Warrants to purchase 5,097,258 shares of Common Stock; and 35,750
      shares of common stock issuable upon exercise of Class D Warrants.

3.    5,912,598 shares of common stock of the Issuer, par value $0.01 per share
      (the "Common Stock") and warrants to purchase 2,803,483 shares of Common
      Stock owned by Aries Domestic Fund, L.P., a Delaware limited partnership
      ("Aries I"). Includes 2,415,707 shares of Common Stock owned directly by
      Aries I and 513,728 shares of Common Stock issuable upon conversion of
      70,100 shares of Series A Convertible Preferred Stock owned by the Aries
      and 2,983,163 shares of Common Stock issuable upon conversion of 26,754
      shares of Series D Convertible Preferred Stock. Also includes 39,557
      shares of Common Stock issuable upon conversion of 350 shares of Series D
      Convertible Preferred Stock underlying warrants to purchase such shares
      owned by Aries I; Bridge Loan Warrants and Line of Credit Warrants to
      purchase 2,744,676 shares of Common Stock; and 19,250 shares of Common
      Stock issuable upon exercise of Class D Warrants.

4.    507,631 shares of Common Stock owned by Aries Domestic Fund II, L.P.
      ("Aries II" and collectively with Aries I and the Master Fund, the "Aries
      Funds")


                                  Page 3 of 3



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission